ID   PTPR2_RAT               Reviewed;        1004 AA.
AC   Q63475;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   24-JUL-2024, entry version 164.
DE   RecName: Full=Receptor-type tyrosine-protein phosphatase N2;
DE            Short=R-PTP-N2;
DE            EC=3.1.3.- {ECO:0000305|PubMed:20097759};
DE            EC=3.1.3.48;
DE   AltName: Full=PTP NE-6;
DE            Short=PTPNE6;
DE   AltName: Full=Phogrin {ECO:0000303|PubMed:14597614};
DE   Contains:
DE     RecName: Full=IA-2beta60;
DE   Flags: Precursor;
GN   Name=Ptprn2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEOLYTIC PROCESSING.
RC   STRAIN=New England Deaconess Hospital; TISSUE=Insulinoma;
RX   PubMed=8663434; DOI=10.1074/jbc.271.30.18161;
RA   Wasmeier C., Hutton J.C.;
RT   "Molecular cloning of phogrin, a protein-tyrosine phosphatase homologue
RT   localized to insulin secretory granule membranes.";
RL   J. Biol. Chem. 271:18161-18170(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley;
RA   Fitzgerald L.R., Walton K.M., Dixon J.E., Largent B.L.;
RL   Submitted (NOV-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   PHOSPHORYLATION AT SER-681 AND THR-700.
RX   PubMed=11353772; DOI=10.1074/jbc.m102580200;
RA   Wasmeier C., Hutton J.C.;
RT   "Secretagogue-dependent phosphorylation of the insulin granule membrane
RT   protein phogrin is mediated by cAMP-dependent protein kinase.";
RL   J. Biol. Chem. 276:31919-31928(2001).
RN   [4]
RP   SUBCELLULAR LOCATION.
RX   PubMed=14597614; DOI=10.1074/jbc.m310104200;
RA   Hosaka M., Suda M., Sakai Y., Izumi T., Watanabe T., Takeuchi T.;
RT   "Secretogranin III binds to cholesterol in the secretory granule membrane
RT   as an adapter for chromogranin A.";
RL   J. Biol. Chem. 279:3627-3634(2004).
RN   [5]
RP   SUBCELLULAR LOCATION, MUTAGENESIS OF TYR-655, TYROSINE-BASED
RP   INTERNALIZATION MOTIF, AND INTERACTION WITH AP2M1.
RX   PubMed=15882444; DOI=10.1111/j.1600-0854.2005.00292.x;
RA   Wasmeier C., Burgos P.V., Trudeau T., Davidson H.W., Hutton J.C.;
RT   "An extended tyrosine-targeting motif for endocytosis and recycling of the
RT   dense-core vesicle membrane protein phogrin.";
RL   Traffic 6:474-487(2005).
RN   [6]
RP   FUNCTION AS PHOSPHATIDYLINOSITOL PHOSPHATASE, CATALYTIC ACTIVITY, AND LACK
RP   OF FUNCTION AS PROTEIN TYROSINE PHOSPHATASE.
RX   PubMed=20097759; DOI=10.1074/jbc.m109.066563;
RA   Caromile L.A., Oganesian A., Coats S.A., Seifert R.A., Bowen-Pope D.F.;
RT   "The neurosecretory vesicle protein phogrin functions as a
RT   phosphatidylinositol phosphatase to regulate insulin secretion.";
RL   J. Biol. Chem. 285:10487-10496(2010).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-340 AND SER-687, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [8]
RP   INTERACTION WITH MYO5A.
RX   PubMed=25744490; DOI=10.1007/s00418-015-1311-9;
RA   Wang Z., Peng T., Wu H., He J., Li H.;
RT   "HAP1 helps to regulate actin-based transport of insulin-containing
RT   granules in pancreatic beta cells.";
RL   Histochem. Cell Biol. 144:39-48(2015).
CC   -!- FUNCTION: Plays a role in vesicle-mediated secretory processes.
CC       Required for normal accumulation of secretory vesicles in hippocampus,
CC       pituitary and pancreatic islets. Required for the accumulation of
CC       normal levels of insulin-containing vesicles and preventing their
CC       degradation. Plays a role in insulin secretion in response to glucose
CC       stimuli. Required for normal accumulation of the neurotransmitters
CC       norepinephrine, dopamine and serotonin in the brain. In females, but
CC       not in males, required for normal accumulation and secretion of
CC       pituitary hormones, such as luteinizing hormone (LH) and follicle-
CC       stimulating hormone (FSH). Required to maintain normal levels of renin
CC       expression and renin release. May regulate catalytic active protein-
CC       tyrosine phosphatases such as PTPRA through dimerization (By
CC       similarity). Has phosphatidylinositol phosphatase activity; the PIPase
CC       activity is involved in its ability to regulate insulin secretion. Can
CC       dephosphorylate phosphatidylinositol 4,5-biphosphate,
CC       phosphatidylinositol 5-phosphate and phosphatidylinositol 3-phosphate
CC       (PubMed:20097759). Regulates PI(4,5)P2 level in the plasma membrane and
CC       localization of cofilin at the plasma membrane and thus is indirectly
CC       involved in regulation of actin dynamics related to cell migration and
CC       metastasis; upon hydrolyzation of PI(4,5)P2 cofilin is released from
CC       the plasma membrane and acts in the cytoplasm in severing F-actin
CC       filaments (By similarity). {ECO:0000250|UniProtKB:P80560,
CC       ECO:0000269|PubMed:20097759}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620; EC=3.1.3.48; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU10044};
CC   -!- SUBUNIT: Self-associates. Interacts (via cytoplasmic domain) with PTPRN
CC       (via cytoplasmic domain). Interacts (precursor form) with CPE.
CC       Interacts with HAP1. Interacts with AP2A1 or AP2A2 and AP1G1;
CC       indicative for an association with adaptor protein complex 2 (AP-2) and
CC       adaptor protein complex 1 (AP-1) (By similarity). Interacts with AP2M1;
CC       indicative for an association with adaptor protein complex 2 (AP-2)
CC       (PubMed:15882444). Interacts with MYO5A (PubMed:25744490).
CC       {ECO:0000250|UniProtKB:P80560, ECO:0000269|PubMed:25744490}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle membrane
CC       {ECO:0000269|PubMed:14597614}; Single-pass type I membrane protein
CC       {ECO:0000269|PubMed:14597614}. Cytoplasmic vesicle, secretory vesicle,
CC       synaptic vesicle membrane {ECO:0000250|UniProtKB:P80560}; Single-pass
CC       type I membrane protein {ECO:0000250|UniProtKB:P80560}.
CC       Note=Predominantly found on dense-core secretory granules. Sorting to
CC       secretory granules in part is dependent of the N-terminal propeptide
CC       domain of the precursor and its interaction with CPE (By similarity).
CC       Transiently found at the cell membrane, when secretory vesicles fuse
CC       with the cell membrane to release their cargo. Is then endocytosed and
CC       recycled to secretory vesicles involving clathrin-dependent AP2-
CC       mediated endocytosis (PubMed:15882444). Recycled via STX6- but not
CC       TTTGN1/TGN38-containing compartments (By similarity).
CC       {ECO:0000250|UniProtKB:P80560, ECO:0000269|PubMed:15882444,
CC       ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: [IA-2beta60]: Cytoplasmic vesicle, secretory
CC       vesicle membrane {ECO:0000305}.
CC   -!- DOMAIN: The tyrosine-based internalization signal is proposed to
CC       function at the level of clathrin-mediated endocytosis and recycling.
CC       {ECO:0000305|PubMed:15882444}.
CC   -!- DOMAIN: The leucine-based sorting signal is proposed to function in
CC       trafficking at the plasma membrane. {ECO:0000250|UniProtKB:P80560}.
CC   -!- PTM: Subject to proteolytic cleavage at multiple sites.
CC       {ECO:0000250|UniProtKB:P80560}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Receptor class 8 subfamily. {ECO:0000305}.
CC   -!- CAUTION: Has no tyrosine-protein phosphatase activity at mild acidic
CC       conditions (pH 5.5). The in vivo relevance of the low PPase activity
CC       for the human protein at acidic conditions (pH 4.5) is questioned. This
CC       catalytic activity seems to be affected by the replacement of a highly
CC       conserved residue in the tyrosine-protein phosphatase domain.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z50735; CAA90600.1; -; mRNA.
DR   EMBL; U73458; AAC08036.1; -; mRNA.
DR   RefSeq; NP_113788.1; NM_031600.1.
DR   AlphaFoldDB; Q63475; -.
DR   SMR; Q63475; -.
DR   STRING; 10116.ENSRNOP00000006942; -.
DR   GlyCosmos; Q63475; 1 site, No reported glycans.
DR   GlyGen; Q63475; 1 site.
DR   iPTMnet; Q63475; -.
DR   PhosphoSitePlus; Q63475; -.
DR   SwissPalm; Q63475; -.
DR   jPOST; Q63475; -.
DR   PaxDb; 10116-ENSRNOP00000006942; -.
DR   Ensembl; ENSRNOT00000006942.5; ENSRNOP00000006942.4; ENSRNOG00000005003.5.
DR   Ensembl; ENSRNOT00055008052; ENSRNOP00055006063; ENSRNOG00055005045.
DR   Ensembl; ENSRNOT00060025292; ENSRNOP00060020152; ENSRNOG00060014787.
DR   Ensembl; ENSRNOT00065011395; ENSRNOP00065008299; ENSRNOG00065007303.
DR   GeneID; 29714; -.
DR   KEGG; rno:29714; -.
DR   UCSC; RGD:61904; rat.
DR   AGR; RGD:61904; -.
DR   CTD; 5799; -.
DR   RGD; 61904; Ptprn2.
DR   eggNOG; KOG0793; Eukaryota.
DR   GeneTree; ENSGT00940000154095; -.
DR   HOGENOM; CLU_007905_0_0_1; -.
DR   InParanoid; Q63475; -.
DR   OrthoDB; 2911650at2759; -.
DR   PhylomeDB; Q63475; -.
DR   TreeFam; TF351976; -.
DR   Reactome; R-RNO-6798695; Neutrophil degranulation.
DR   PRO; PR:Q63475; -.
DR   Proteomes; UP000002494; Chromosome 6.
DR   Bgee; ENSRNOG00000005003; Expressed in frontal cortex and 9 other cell types or tissues.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; IDA:RGD.
DR   GO; GO:0098793; C:presynapse; IDA:SynGO.
DR   GO; GO:0043235; C:receptor complex; ISO:RGD.
DR   GO; GO:0030141; C:secretory granule; IDA:RGD.
DR   GO; GO:0030667; C:secretory granule membrane; ISS:UniProtKB.
DR   GO; GO:0045202; C:synapse; IBA:GO_Central.
DR   GO; GO:0030672; C:synaptic vesicle membrane; IDA:SynGO.
DR   GO; GO:0043195; C:terminal bouton; IDA:RGD.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0035773; P:insulin secretion involved in cellular response to glucose stimulus; ISS:UniProtKB.
DR   GO; GO:0006629; P:lipid metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0007269; P:neurotransmitter secretion; ISS:UniProtKB.
DR   GO; GO:0051046; P:regulation of secretion; IBA:GO_Central.
DR   CDD; cd14610; R-PTP-N2; 1.
DR   Gene3D; 3.90.190.10; Protein tyrosine phosphatase superfamily; 1.
DR   Gene3D; 3.30.70.2470; Protein-tyrosine phosphatase receptor IA-2 ectodomain; 1.
DR   InterPro; IPR033522; IA-2/IA-2_beta.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTP_cat.
DR   InterPro; IPR021613; Receptor_IA-2_dom.
DR   InterPro; IPR038112; Receptor_IA-2_ectodomain_sf.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; Tyr_Pase_dom.
DR   PANTHER; PTHR46106; IA-2 PROTEIN TYROSINE PHOSPHATASE, ISOFORM C; 1.
DR   PANTHER; PTHR46106:SF5; RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE N2; 1.
DR   Pfam; PF11548; Receptor_IA-2; 1.
DR   Pfam; PF00102; Y_phosphatase; 1.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00194; PTPc; 1.
DR   SMART; SM00404; PTPc_motif; 1.
DR   SMART; SM01305; RESP18; 1.
DR   SUPFAM; SSF52799; (Phosphotyrosine protein) phosphatases II; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Cytoplasmic vesicle; Glycoprotein; Hydrolase;
KW   Lipid metabolism; Membrane; Methylation; Phospholipid metabolism;
KW   Phosphoprotein; Protein phosphatase; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..27
FT                   /evidence="ECO:0000255"
FT   CHAIN           28..1004
FT                   /note="Receptor-type tyrosine-protein phosphatase N2"
FT                   /id="PRO_0000025457"
FT   CHAIN           491..1004
FT                   /note="IA-2beta60"
FT                   /evidence="ECO:0000250|UniProtKB:P80560"
FT                   /id="PRO_0000438073"
FT   TOPO_DOM        28..603
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        604..624
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        625..1004
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          734..994
FT                   /note="Tyrosine-protein phosphatase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160"
FT   REGION          1..409
FT                   /note="Involved in localization to secretory granules;
FT                   interaction with CPE"
FT                   /evidence="ECO:0000250|UniProtKB:P80560"
FT   REGION          274..294
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          333..360
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          393..459
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          665..710
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           655..664
FT                   /note="Tyrosine-based internalization motif"
FT                   /evidence="ECO:0000305|PubMed:15882444"
FT   MOTIF           993..999
FT                   /note="Leucine-based sorting signal"
FT                   /evidence="ECO:0000250|UniProtKB:P80560"
FT   COMPBIAS        407..454
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        674..710
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        934
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160,
FT                   ECO:0000255|PROSITE-ProRule:PRU10044"
FT   BINDING         902
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         934..940
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         979
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   SITE            415..416
FT                   /note="Cleavage"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         259
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P80560"
FT   MOD_RES         340
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         424
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P80560"
FT   MOD_RES         425
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P80560"
FT   MOD_RES         681
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000269|PubMed:11353772"
FT   MOD_RES         687
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         700
FT                   /note="Phosphothreonine; by PKA"
FT                   /evidence="ECO:0000269|PubMed:11353772"
FT   MOD_RES         959
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92932"
FT   CARBOHYD        553
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   MUTAGEN         655
FT                   /note="Y->A: Impairs internalization; decreases interaction
FT                   with AP2M1."
FT                   /evidence="ECO:0000269|PubMed:15882444"
SQ   SEQUENCE   1004 AA;  111863 MW;  A73929E11B486FB2 CRC64;
     MGLPLPLLLL LLLPPPLPRA LPAPASARGR QLPGRLGCLF EDGLCGSLET CVNDGVFGRC
     QKVPALDTYR YEVSPGALLH LRIILQKLSR TGFTWQDDYT QRVIAQELSN LPKAYLWHEE
     ASSPARSLQQ NADNEKWFSL ESEVALAKTL RRYLPYLELL SQAPTANAHP RIDHETRPVK
     GEDSSPENIL TYVAHTSALT YPPATRVKYP DNLLRPLSRL QPDELSPKVD SDIDKQKLIA
     ALGAYTAQRP PGENDPEPRY LVHSPMRAPR PFAAPALSQR WPLPPGDSKD SLSMGDDTLL
     RSLLKDLQQQ AEVDRLGSLK LEEQADSIAG AIQSDPVEGS QESHGRGAEG QLREQADAPE
     EMLQDHRLPE VDDPAAYKEV SRLSFKLGDL LKDHGSPLLP EAPLLEKSSR AEMKKSEQPE
     EVLSSEEETA GVEHVKSRTY SKDLLERKPN SEPQPWRLED QFQNRAPEVW EDEQNLKLAA
     QGPPSGGLQL EVQPSEEEQQ GYILTGNNPL SPEKGKQLMD EVAHLLRVPS SFFADVKVLG
     PAVIFKVSAN IQNMTTADVT KAAVDNKDEL EKATGLTILQ SGIRPKGKLK LLPHPEEQED
     STKFIVLTFL SIACILAVLL ASSLAYCLRH NSHYKLKEKL SGLGADPSAD ATEAYQELCR
     QRMAVRPQDH SEGPHTSRIN SVSSQLSDGP MPSPSARSST SSWSEEPAQS NMDISTGHMI
     LAYMEDHLKN KNRLEKEWEA LCAYQAEPDS SLVAQREENA PKNRSLAVLT YDHSRILLKS
     ENSHSNSDYI NASPIMDHDP RNPAYIATQG PLPATVADFW QMVWESGCAV IVMLTPLSEN
     GVRQCHHYWP DEGSNVYHVY EVNLVSEHIW CQDFLVRSFY LKNLQTNETR TVTQFHFLSW
     YDQGVPSSTR SLLDFRRKVN KCYRGRSCPI IVHCSDGAGR SGTYVLIDMV LNKMAKGAKE
     IDIAATLEHL RDQRPGMVQT KEQFEFALTA VAEEVNAILK ALPQ
//
